Monte Rosa Therapeutics
GLUE
#7806
Rank
โ‚ฌ0.22 B
Marketcap
3,60ย โ‚ฌ
Share price
1.54%
Change (1 day)
-44.77%
Change (1 year)

Revenue for Monte Rosa Therapeutics (GLUE)

Revenue in 2024 (TTM): โ‚ฌ71.89 Million

According to Monte Rosa Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ68.98 Million. an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Monte Rosa Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ72.67 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A